Does Adding Posterior Block to SFIB Increase the Quality of Analgesia in Hip Fractures?
Launched by SAMSUN UNIVERSITY · Feb 17, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding a specific type of pain relief technique, called a Deep Posterior Gluteal Compartment Block, to an existing pain management method called a Suprainguinal Fascia Iliaca Compartment Block can improve pain control for patients undergoing hip surgery. The researchers want to find out if this combination helps reduce pain better than just using the SFICB alone, especially in terms of how much pain medication patients need after surgery.
To participate in this study, patients must be between 18 and 90 years old and able to undergo surgery with spinal anesthesia for a procedure that lasts no longer than two hours. They should also be in good health, classified as ASA I, II, or III, meaning they have mild to moderate health issues. Participants will receive the assigned pain management techniques and will be monitored for their pain levels and medication needs during and after surgery. It's important to note that some people may not qualify due to certain medical conditions, allergies, or medications. If you or a family member are considering participating, you can learn more about what to expect and the eligibility requirements.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteering to participate in the study
- • Patients between the ages of 18-90
- • ASA I, II, III
- • Patients whose surgery duration does not exceed 2 hours
- • Patients who will undergo surgery under spinal anesthesia
- Exclusion Criteria:
- • Patients who do not want to participate in the study/do not give consent
- • Patients with a condition that prevents regional anesthesia
- • Patients with cognitive dysfunction who are unable to evaluate the NRS score and who cannot use PCA (Patient Controlled Analgesia Device)
- • History of hypersensitivity or allergy to local anesthetics
- • Patients with psychiatric disorders and those using psychiatric medications
- • Presence of hematological disease
- • Presence of oncological disease
- • Patients with serious major organ failure
- • Presence of multiple fractures
- • Patients with alcohol or drug addiction
- • Patients who have used analgesic drugs up to 12 hours before surgery
- • ASA IV-V patients
- • Morbidly obese patients
About Samsun University
Samsun University is a leading academic institution dedicated to advancing medical research and clinical innovation. Committed to improving healthcare outcomes, the university sponsors a range of clinical trials that focus on diverse therapeutic areas. With a robust infrastructure and a team of experienced researchers, Samsun University fosters collaboration between multidisciplinary experts to ensure the highest standards of scientific rigor and ethical compliance. By integrating cutting-edge technology and evidence-based practices, the university aims to contribute valuable insights to the medical community and enhance patient care through its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, Ilkadım, Turkey
Samsun, , Turkey
Patients applied
Trial Officials
HATİCE SELÇUK KUŞDERCİ
Study Director
SAMSUN UNİVERSITY
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported